Methylenetetrahydrofolate Reductase C677T Polymorphism, Hypertension, and Risks of Stroke: A Prospective Nested Case–control Study

Dayi Hu,Jiguang Wang,Hua Yao,Jinxiu Lin,Yuhua Liao,Shanqun Jiang,Yu Wang,Houxun Xing,Binyan Wang,Yong Huo,Xiping Xu

DOI: https://doi.org/10.1016/j.ijcard.2009.09.222

IF: 4.039

2009-01-01

International Journal of Cardiology

Abstract:Background Hyperhomocysteinemia is a risk factor for cardiovascular disease. To date, no prospective studies have examined joint effects of Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, hyperhomocysteinemia and conventional vascular risk factors on risks of stroke and death by stroke. Methods We prospectively followed-up 39,165 subjects from nine communities around Anqing, China between March, 1995 and April, 2005, with an average follow-up period of 6.2 years. None of the subjects had any history of vascular events at baseline. At follow-up, we identified 251 subjects with incident stroke, 116 of whom had complete MTHFR C677T genotyping data and plasma samples were included in the analysis. We selected 116 matched controls without vascular events. We used logistic regression to investigate the independent and joint associations of hypertension and C677T genotype (and effect modification by plasma Hcy level) with the odds of case statuses defined by 1) stroke (n=116 pairs) and 2) death by stroke (n=78 pairs) after adjustment for important covariates. Results Hypertension and 677TT genotype were independently associated with case statuses after adjustment for important covariates including plasma log-transformed Hcy level. Relative to non-TT genotype with normal blood pressure, the adjusted odds ratio (95% confidence interval) for case status among hypertensive TT genotype were 8.2 (2.3 to 29.7) for stroke, and 5.3 (1.2 to 21.6) for death by stroke. These odds ratios were even higher among subjects with moderate plasma Hcy levels after excluding subjects with plasma Hcy above 20 μmol/L. Conclusions Our major findings suggested: 1) joint, independent effects of the MTHFR C677T polymorphism and hypertension consistently predicted significantly higher risks of stroke or its death; 2) under modest Hcy levels, the predicted effects on risks for the two primary end points were more pronounced.